Evaluation of the effect of pyrrolidine dithiocarbamate in suppressing inflammation in mice with dextran sodium sulfate-induced colitis

World Journal of Gastroenterology

Volumn 13, Issue 11, 2007, Pages 1666-1671

  Hirata, Ichiro ^a   Yasumoto, Shingo ^b   Toshina, Ken ^b   Inoue, Takuya ^b   Nishikawa, Takashi ^b   Murano, Naoko ^b   Murano, Mitsuyuki ^b   Wang, Fang Yu ^c   Katsu, Ken Ichi ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

DSS induced colitis; Mice; NF B; Pyrrolidine dithiocarbamate; Ulcerative colitis

Indexed keywords

DEXTRAN SULFATE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG MEGADOSE; ENTERITIS; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; MOUSE; NONHUMAN; SCORING SYSTEM; ULCERATIVE COLITIS;

EID: 34248180165     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i11.1666     Document Type: Article

References (21)

1. Israel A. The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol 2000; 10: 129-133
2. Long SM, Laubach VE, Tribble CG, Kaza AK, Fiser SM, Cassada DC, Kern JA, Kron IL. Pyrrolidine dithiocarbamate reduces lung reperfusion injury. J Surg Res 2003; 112: 12-18
3. Bruck R, Aeed H, Schey R, Matas Z, Reifen R, Zaiger G, Hochman A, Avni Y. Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 2002; 36: 370-377
4. Nemeth ZH, Deitch EA, Szabo C, Hasko G. Pyrrolidinedithio carbamate inhibits NF-kappaB activation and IL-8 production in intestinal epithelial cells. Immunol Lett 2003; 85: 41-46
5. Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci 1993; 38: 1722-1734
6. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinico-pathologic study of dextran sulfate sodium experi-mental murine colitis. Lab Invest 1993; 69: 238-249
7. Cheon JH, Kim JS, Kim JM, Kim N, Jung HC, Song IS. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm Bowel Dis 2006; 12: 1152-1161
8. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702
9. Kimura I, Nagahama S, Kawasaki M, Kamiya A, Kataoka M. Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (2). Nippon Yakurigaku Zasshi 1995; 105: 145-152
10. Kimura I, Nagahama S, Kawasaki M, Kamiya A, Kataoka M. Study on the experimental ulcerative colitis (UC) model induced by dextran sulfate sodium (DSS) in rats (2). Nippon Yakurigaku Zasshi 1995; 105: 145-152
11. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998; 42: 477-484
12. Neurath MF. Pathogenesis of inflammatory bowel disease: transcription factors in the spotlight. Gut 1998; 42: 458-459
13. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober W. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 1996; 2: 998-1004
14. Murano M, Maemura K, Hirata I, Toshina K, Nishikawa T, Hamamoto N, Sasaki S, Saitoh O, Katsu K. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin Exp Immunol 2000; 120: 51-58
15. Mallick IH, Yang WX, Winslet MC, Seifalian AM. Pyrrolidine dithiocarbamate reduces ischemia-reperfusion injury of the small intestine. World J Gastroenterol 2005; 11: 7308-7313
16. Malek S, Chen Y, Huxford T, Ghosh G. IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells. J Biol Chem 2001; 276: 45225-45235
17. Topping RJ, Jones MM. Optimal dithiocarbamate structure for immunomodulator action. Med Hypotheses 1988; 27: 55-57
18. Cuzzocrea S, Chatterjee PK, Mazzon E, Dugo L, Serraino I, Britti D, Mazzullo G, Caputi AP, Thiemermann C. Pyrrolidine dithiocarbamate attenuates the development of acute and chronic inflammation. Br J Pharmacol 2002; 135: 496-510
19. Shintani N, Nakajima T, Nakakubo H, Nagai H, Kagitani Y, Takizawa H, Asakura H. Intravenous immunoglobulin (IVIG) treatment of experimental colitis induced by dextran sulfate sodium in rats. Clin Exp Immunol 1997; 108: 340-345
20. Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol 1999; 19: 2690-2698
21. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS Jr. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999; 19: 5785-5799